Insulin aspart, recombinant Subcutaneous and Resorcinol and sulfur Topical
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Resorcinol and sulfur Topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: resorcinol / sulfur topical
Brand name:
Synonyms: Resorcinol and sulfur (Topical)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Resorcinol topical
- Insulin aspart, recombinant Subcutaneous-Respaire-30
- Insulin aspart, recombinant Subcutaneous-Resperal-DM Drops
- Insulin aspart, recombinant Subcutaneous-Respi-TANN
- Insulin aspart, recombinant Subcutaneous-Respi-Tann Pd
- Insulin aspart, recombinant Subcutaneous-Respigam
- Resorcinol and sulfur Topical-Insulin degludec
- Resorcinol and sulfur Topical-Insulin Degludec (U-100) Prefilled Pens
- Resorcinol and sulfur Topical-Insulin Degludec (U-100) Vials
- Resorcinol and sulfur Topical-Insulin Degludec (U-200) Prefilled Pens
- Resorcinol and sulfur Topical-Insulin degludec and liraglutide
- Resorcinol and sulfur Topical-Insulin degludec and liraglutide Subcutaneous